RE: Webcast10 Dec 2019 15:30
1) I'd agree presentation doesn't come across as negative as the RNS may have, although perhaps the detail of the webcast prevented it being released sooner. I'd think the board was not anticipating such a negative reaction and had always intended to release later in day, as with many companies.
2) I also felt it slightly odd that a drug has been tested and there was a mention of not knowing why it works. They developed it, so must have to give reassurance on its effects and reasoning, perhaps one for the FDA to analyse further
Overall, the presentation seemed detailed and enough positives in the not to distant future.